Literature DB >> 34165239

Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.

Fredrik Kahn1, Oonagh Shannon1, Lars Björck1.   

Abstract

Several recent reports have independently described a rare thrombosis with thrombocytopenia syndrome (TTS) post vaccination with ChAdOx1 nCoV-19. In J. Thromb. Haemost., Ankerlund Blauenfeldt et al. [1] described the clinical presentation of a case of fatal acute ischemic stroke associated with profound thrombocytopenia. The pathogenesis behind this case may involve mechanisms similarly to autoimmune heparin-induced thrombocytopenia (HIT) since anti-platelet factor 4(PF-4) antibodies were detected in the patient plasma. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2021        PMID: 34165239     DOI: 10.1111/jth.15433

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  2 in total

1.  Reply to the letter entitled "Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme".

Authors:  Yves Gruel; Caroline Vayne; Jérôme Rollin; Claire Pouplard
Journal:  J Thromb Haemost       Date:  2021-07-30       Impact factor: 16.036

2.  Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT from Gruel et al.: RESPONSE from Kahn et al.

Authors:  Fredrik Kahn; Oongh Shannon; Lars Björck
Journal:  J Thromb Haemost       Date:  2021-08-05       Impact factor: 16.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.